- Article- Efficacy of remdesivir in high-risk non-hospitalized patients- April 1, 2022- Dr. Taghvaei Clinical question: Does the use of remdesivir therapy in symptomatic, non-hospitalized, COVID-19 patients reduce disease progression and hospitalization? Background: Remdesivir... 
- Article- The evolution of the hospitalist- March 30, 2022- Dr. Ramanathan Dr. Chmelik The term hospitalist was coined in 1996 in a New England Journal of Medicine article written by Dr. Robert Wachter—often considered the father of the field. The need... 
- Article- Learn to surf- March 3, 2022- Recently, three hospitalists turned what could have been a webinar focused on venting into something positive and inspirational. Sharmila Dissanaike, MD, FACS, FCCM, a hospitalist and a trauma,... 
- Article- Characteristics of hospitalized patients whose substance use increased amid the impacts of COVID-19- March 3, 2022- Nearly 20 million U.S. adults experience a substance use disorder (SUD) annually,1 leading to more than 650 thousand hospital admissions.2 Large-scale crises like the COVID-19 pandemic can... 
- Article- How to manage patients with eating disorders in the inpatient setting- March 1, 2022- Case Dr. Wimberly A 25-year-old female pharmacy student is brought to the emergency department by her parents after a presyncopal episode while at home for a school break. Her parents are... 
- Article- Outpatient COVID-19 therapeutics reduce hospitalization and mortality- February 10, 2022- Matching the right patient to the right therapeutic at the right time In late 2021 and early 2022, the Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for the... 
- Article- To treat or not to treat: interpreting syphilis serologies- February 3, 2022- Case A 32-year-old man with history of intravenous heroin use presents to the emergency department (ED) for fevers and redness with purulence over the left forearm. He is started on IV vancomycin... 
- Article- Can I use DOAC in a patient with renal disease?- February 3, 2022- Case A 76-year-old man is diagnosed with non-valvular atrial fibrillation. His comorbid conditions are hypertension, diabetes complicated by neuropathy, and chronic kidney disease stage 3. His... 
- Article- A proposed scoring system to assess COVID-19-induced coagulopathy and stratification of patients for anticoagulation therapy based on risk categories- February 3, 2022- Clinical question: Can a proposed new scoring system triage and assess risk in COVID-19 patients with coagulopathy? Dr. Ajala Background: COVID-19-induced coagulopathy (CIC), marked... 
- Article- Direct oral anticoagulants may be safe in cancer-related venous thromboembolisms, but use caution with gastrointestinal malignancies- February 3, 2022- Clinical question: Are direct oral anticoagulants (DOACs) a suitable alternative to low molecular weight heparin (LMWH) for treatment of venous thromboembolism (VTE) in patients with underlying...